The rs671 polymorphism in ALDH2 was pinpointed as a risk factor for the occurrence of death from cardio-cerebrovascular complications in patients with type 2 diabetes [64] and has recently been characterized as a novel regulator of cholesterol biosynthesis [65]. This evidence concerns the gene ALDH2 and type 2 diabetes mellitus.